66304-1-Ig

antibody from Proteintech Group

Targeting: CD47 IAP, MER6, OA3

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Antibody Data

Product number

66304-1-Ig

Provider

Proteintech Group

Product name

CD47 antibody

Antibody type

Monoclonal

Description

KD/KO validated CD47 antibody (Cat. #66304-1-Ig) is a mouse monoclonal antibody that shows reactivity with human and has been validated for the following applications: FC, WB,ELISA.

Reactivity

Human

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

1E1D8

Vial size

20ul, 150ul

References

Submitted references

Macrophage-biomimetic nanomedicine for targeted therapy of abdominal aortic aneurysm via Nrf2/NF-κB pathway.

Luo Q, Meng W, Wang J, Zhang X, Meng Q, Hu M, Wei S, Yu X, Deng D, Zhang Y, Ma Z, Li S, Wang S, Zhang B, Ding J, Liu J, Zhou J
Theranostics 2026;16(7):3363-3383

---

Metformin suppresses PPARδ-driven CD47 transcription to enhance macrophage phagocytosis in lung cancer.

Cui Q, Wang H, Yu H, Li Y, Wang Y, Shi J, Hou Y
The Journal of biological chemistry 2026 Mar;302(3):111159

---

Cancer cell membrane and iRGD peptide co-modified cantharidin liposomes for targeted therapy and immunotherapy of triple-negative breast cancer.

Guo Q, Wang S, Zhong Z, Zhou L, Xia X
Free radical biology & medicine 2026 Jun;249:273-291

---

A pH-Responsive Biomimetic Antioxidant Nanoplatform with Dual Renal Targeting for Synergistic Therapy of Acute Kidney Injury.

Zhang S, Xie Y, Zhang L, Qi Y, Liao Q, Xu C, Yang S, Zhou H, Tan Q, Qi S
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Jan;13(5):e15664

---

Arsenic sulfide enhances the therapeutic effect of hepatocellular carcinoma immunotherapy through STAT3-THBS1/CD47 pathway.

Kang T, Feng Z, Cai Y, Huang R, Wang R, Liu Z, Lu S, Xie S, Liu H, Chen S
Frontiers in immunology 2025;16:1612318

---

Resolvin D2 limits senescent cell accumulation in atherosclerotic plaques.

Lipscomb M, Salfate Del Rio I, Eid M, Rahtes A, Martino G, Sadhu S, Khan S, MacNamara KC, Fredman G
Vascular pharmacology 2025 Sep;160:107527

---

TNAP-induced CD47 membrane expression enhances TGF-β1 conversion in liver fibrosis.

Gao L, Peng F, Qi P, Zhang H, Chi H, Deng L, Liang X, Sun M, Ma W, Yang C, Liu Q, Wei X, Li Y, Zhao J
Hepatology communications 2025 Oct 1;9(10)

---

Host Cell Membrane-Cloaked Nanomedicine Reprograms Endothelial Surface for Enhanced Patency in Allogeneic Vascular Grafts.

Pei J, Qin Y, Liu Q, Sun D, Qu X, Yang G, Yang D, Gao T, Liu Y, Sun H, Guo X, Xu Y, Fan Y, Zhu C
Advanced materials (Deerfield Beach, Fla.) 2025 Nov;37(44):e06653

---

Engineered macrophage membrane-coated nanoparticles attenuate calcium oxalate nephrocalcinosis-induced kidney injury by reducing oxidative stress and pyroptosis.

Ba X, Ye T, He Y, Tong Y, Shang H, Wu J, Deng W, Zhong Z, Yang X, Wang K, Xie Y, Jiang K, Guo X, Tang K
Acta biomaterialia 2025 Mar 15;195:479-495

---

ROS Responsive Cerium Oxide Biomimetic Nanoparticles Alleviates Calcium Oxalate Crystals Induced Kidney Injury via Suppressing Oxidative Stress and M1 Macrophage Polarization.

He Y, Peng E, Ba X, Wu J, Deng W, Huang Q, Tong Y, Shang H, Zhong Z, Liu X, Zhang Y, Ye T, Yang X, Wang K, Xie Y, Jiang K, Xia D, Chen Z, Tang K
Small (Weinheim an der Bergstrasse, Germany) 2025 Jan;21(3):e2405417

---

CD47-targeted liposomal chemotherapy upregulates CD47 expression and induces microsatellite instability which enhances cancer immunotherapy.

Liu Q, Liang J, Gu Y, Gao H, Yang D, Jiang Y, Zhang J, Lei Q, Yang B
Journal of controlled release : official journal of the Controlled Release Society 2025 Dec 10;388(Pt 2):114351

---

Biomimetic Delivery of Cisplatin for Efficient Immunotherapy of Gasdermin E-Positive Hepatocellular Carcinoma via a Pt Concentration-Dependent Minimalist Pyroptosis Strategy.

Huang Y, He S, Xu J, Zou T, Liu J, Huang C, Chen Y, Liu H, Lei A, Wei H, Yu CY
Advanced healthcare materials 2025 Aug;14(21):e2500766

---

Dual-Regulated Biomimetic Nanocomposites For Promoted Tumor Photodynamic Immunotherapy.

Liao L, Liu Y, Li X, Jiang Z, Jiang Z, Yao J
ACS applied materials & interfaces 2025 Apr 9;17(14):20919-20931

---

Bispecific Nanobody-Aptamer Conjugates for Enhanced Cancer Therapy in Solid Tumors.

Wang Y, Chen J, Zhang S, Jiang H, Zhu J, Jiang G, Liu Y, Zhu Y, Li J
Small (Weinheim an der Bergstrasse, Germany) 2024 Jun;20(25):e2308265

---

Antibody nanoparticle conjugate-based targeted immunotherapy for non-small cell lung cancer.

Saha T, Fojtů M, Nagar AV, Thurakkal L, Srinivasan BB, Mukherjee M, Sibiyon A, Aggarwal H, Samuel A, Dash C, Jang HL, Sengupta S
Science advances 2024 Jun 14;10(24):eadi2046

---

Cancer cell membrane-camouflaged paclitaxel/PLGA nanoparticles for targeted therapy against lung cancer.

Zhou J, Wan S, Wu Y, Hu H, Liu Y, Liao Z, Xu M, Wu J, Fan Q
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2024 Aug;177:117102

---

Restoration of miR-299-3p promotes efferocytosis and ameliorates atherosclerosis via repressing CD47 in mice.

Zhu Y, Ren S, Huang H, Wu J, You X, Gao J, Ren Y, Wang R, Zhao W, Tan S
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2024 Aug 15;38(15):e23857

---

Endothelial transferrin receptor 1 contributes to thrombogenesis through cascade ferroptosis.

Ma H, Huang Y, Tian W, Liu J, Yan X, Ma L, Lai J
Redox biology 2024 Apr;70:103041

---

Enterolactone and trabectedin suppress epithelial ovarian cancer synergistically via upregulating THBS1.

Zeng Z, Lin C, Zhang MC, Kossinna P, Wang P, Cao D, Wang J, Xu M, Wang X, Li Q, Xu X, Yang H, Zhu S, Liu GR, Xie K, Yang J, Luo Y, Wang Y, Zhang XH, Lin J, Chen H, Liu SL, Liu H
Phytotherapy research : PTR 2023 Oct;37(10):4722-4739

---

Platelet-mimetic nano-sensor for combating postoperative recurrence and wound infection of triple-negative breast cancer.

Liu Y, Qi Y, Chen C, Jin Y, Du S, Qiao J, Yao J
Journal of controlled release : official journal of the Controlled Release Society 2023 Oct;362:396-408

---

Long Circulating Cancer Cell-Targeted Bionic Nanocarriers Enable Synergistic Combinatorial Therapy in Colon Cancer.

Zheng Y, Guo W, Hu L, Xiao Z, Yang X, Cao Z, Cao J
ACS applied materials & interfaces 2023 May 17;15(19):22843-22853

---

Remodeling Collagen Microenvironment in Liver Using a Biomimetic Nano-Regulator for Reversal of Liver Fibrosis.

Liang Y, Wang J, Xu C, Han W, Wu S, Wu Y, Zhang J, Liu J, Zhang Z, Shi J, Zhang K
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2023 Jun;10(18):e2300127

---

B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy.

Chen S, Zhan S, Ding S, Zhang Q, Xuan H, Zhang X, Cao L
Journal of cancer research and clinical oncology 2023 Dec;149(18):16609-16621

---

CD47 interactions with exportin-1 limit the targeting of m(7)G-modified RNAs to extracellular vesicles.

Kaur S, Saldana AC, Elkahloun AG, Petersen JD, Arakelyan A, Singh SP, Jenkins LM, Kuo B, Reginauld B, Jordan DG, Tran AD, Wu W, Zimmerberg J, Margolis L, Roberts DD
Journal of cell communication and signaling 2022 Sep;16(3):397-419

---

Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers.

Song M, Dong S, An X, Zhang W, Shen N, Li Y, Guo C, Liu C, Li X, Chen S
Journal of controlled release : official journal of the Controlled Release Society 2022 May;345:744-754

---

Naturally Equipped Urinary Exosomes Coated Poly (2-ethyl-2-oxazoline)-Poly (D, L-lactide) Nanocarriers for the Pre-Clinical Translation of Breast Cancer.

Ni J, Mi Y, Wang B, Zhu Y, Ding Y, Ding Y, Li X
Bioengineering (Basel, Switzerland) 2022 Aug 3;9(8)

---

Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by OSCC.

Chen H, Deng J, Yao X, He Y, Li H, Jian Z, Tang Y, Zhang X, Zhang J, Dai H
Journal of nanobiotechnology 2021 Oct 26;19(1):342

---

MicroRNA-148a-3p inhibits cancer progression and is a novel screening biomarker for gastric cancer.

Bao C, Guo L
Journal of clinical laboratory analysis 2020 Oct;34(10):e23454

---

Seedless preparation of Au nanorods by hydroquinone assistant and red blood cell membrane camouflage.

Li J, Wang W, Zhang X, Yao H, Wei Z, Li X, Mu X, Jiang J, Zhang H
RSC advances 2018 Jun 8;8(38):21316-21325